≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_AML_EXALLC for full statistics.

Acute myeloid leukaemia

DOID Endpoint Browser

C3_AML

acute myeloid leukemia: Acute myeloid leukemia (AML) is a group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation. All of them are characterized by clonal expansion of myeloid blasts. AML manifests by fever, pallor, anemia, hemorrhages and recurrent infections.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • HLP_C3_AML
351

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C92.0
  • Cause of death: ICD-9 — 2050A
  • Cause of death: ICD-8 — 20500
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 9840|9861|986[67]|987[1-4]|989[1567]|9910|9920|993[01]
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

351

4. Check minimum number of events

None

351

5. Include endpoints

351

6. Filter based on genotype QC (FinnGen only)

351

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8

Similar endpoints

↥

List of similar endpoints to Acute myeloid leukaemia based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 351 146 205
Unadjusted period prevalence (%) 0.07 0.05 0.09
Median age at first event (years) 65.59 57.96 71.03

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
359
Matched controls
3587
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
323.0
313
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
295.1
241
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
113.2
245.3
260
81
XW000
NOMESCO Finland
Bone marrow biopsy
78.2
181.6
202
58
WW500
NOMESCO Finland
Blood transfusion
29.0
101.6
142
79
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
50.0
100.6
121
36
127
Kela drug reimbursment
Transplant complication
82.5
75.3
83
13
A05AA02
ATC
ursodeoxycholic acid; oral
94.2
69.2
75
10
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
201.3
65.4
66
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
64.6
60
*
A04AA01
ATC
ondansetron; systemic, rectal
13.1
56.5
106
111
J05AB11
ATC
valaciclovir; oral
8.2
49.8
126
222
L03AA02
ATC
filgrastim; parenteral
22.8
49.2
72
39
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.5
46.0
91
103
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.3
40.4
124
276
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.6
38.2
83
109
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.3
38.1
116
253
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
16.1
36.9
61
45
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
394.9
36.7
36
*
R50.9
ICD-10 Finland
Fever, unspecified
5.6
36.6
126
318
J02AC03
ATC
voriconazole; systemic
382.6
35.6
35
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
26.8
35.5
49
21
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
12.9
33.5
61
56
L04AD01
ATC
ciclosporin; systemic
22.7
31.8
46
23
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
31.7
30
*
J01MA12
ATC
levofloxacin; systemic
4.5
31.5
136
426
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
42.2
30.9
38
10
WW200
NOMESCO Finland
Immunization
15.5
30.1
50
37
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
87.6
29.3
32
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
19.9
29.2
44
25
D64.9
ICD-10 Finland
Anaemia, unspecified
5.3
28.5
97
233
D70.89
ICD-10 Finland
Neutropenic splenomegaly
21.9
28.1
41
21
ZX120
NOMESCO Finland
Intravenous
5.8
27.9
87
188
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.1
27.6
60
77
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
27.4
26
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
81.3
27.2
30
*
M04AA01
ATC
allopurinol; systemic
4.4
25.4
105
306
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
25.3
24
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
25.3
24
*
A41.9
ICD-10 Finland
Sepsis, unspecified
9.3
25.3
54
67
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.7
25.1
61
93
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
267.8
25.0
25
*
1DB06
NOMESCO Finland
NA
+∞
24.2
23
*
J02AC04
ATC
posaconazole; systemic
+∞
24.2
23
*
L01BB02
ATC
mercaptopurine; oral
33.7
24.1
31
10
121
Kela drug reimbursment
Severe hypofunction of sexual glands
16.0
24.0
39
27
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.0
24.0
49
56
J02AC01
ATC
fluconazole; systemic
3.3
23.5
159
693
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
58.1
23.4
27
5
C95.9
ICD-10 Finland
Leukaemia, unspecified
244.9
22.9
23
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
22.2
209
1129
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
22.1
21
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
22.1
21
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.2
22.0
47
58
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
233.6
21.8
22
*
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
21.0
20
*
N02AA05
ATC
oxycodone; systemic
3.7
19.3
95
315
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
19.3
104
372
ZX112
NOMESCO Finland
Subcutaneous
11.3
19.1
36
35
2AX04
NOMESCO Finland
NA
+∞
18.9
18
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
18.9
18
*
TGC00
NOMESCO Finland
Bronchial lavation
11.6
18.9
35
33
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
200.0
18.7
19
*
B73
ICPC
Leukaemia
200.0
18.7
19
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
32.0
18.6
24
8
L04AA06
ATC
mycophenolic acid; systemic
16.5
18.3
29
19
Z51.5
ICD-10 Finland
Palliative care
5.9
18.2
53
103
JN4BD
NOMESCO Finland
Extensive body CT
4.0
17.0
73
213
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
94.5
16.7
18
*
TPH00
NOMESCO Finland
Phlebotomy
177.9
16.6
17
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.9
16.2
41
66
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.5
16.0
35
45
1BC07
NOMESCO Finland
NA
+∞
15.7
15
*
ZX121
NOMESCO Finland
Central venous catheter
89.0
15.7
17
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
40.0
15.5
19
5
WW409
NOMESCO Finland
Other aferesis
47.2
15.2
18
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.8
15.1
52
122
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
59.3
14.9
17
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.7
14.7
34
48
J05AB01
ATC
aciclovir; systemic
3.0
14.6
98
400
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
14.1
136
690
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
18.5
14.0
21
12
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
13.6
13
*
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
13.6
13
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
+∞
13.6
13
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
35.6
13.6
17
5
L01XX05
ATC
hydroxycarbamide; oral
13.6
13.6
23
18
J01MA14
ATC
moxifloxacin; systemic
3.8
13.3
59
176
A40.8
ICD-10 Finland
Other streptococcal sepsis
17.6
13.1
20
12
L04AA01
ATC
[U] ciclosporin; systemic
17.6
13.1
20
12
H02AB09
ATC
hydrocortisone; systemic
10.2
12.9
25
26
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
12.8
143
774
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
72.5
12.7
14
*
1DB07
NOMESCO Finland
NA
+∞
12.6
12
*
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
12.6
12
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.6
11.7
101
474
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
11.5
11
*
ZXD05
NOMESCO Finland
Urgent procedure
2.3
11.4
133
725
H02AB04
ATC
methylprednisolone; systemic
2.9
11.3
74
292
N05BA06
ATC
lorazepam; systemic, sublingual
5.0
11.3
36
78
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
11.7
11.2
20
18
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
11.1
10.9
20
19
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
11.1
10.9
20
19
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
22.3
10.8
15
7
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
10.5
10
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.3
10.3
27
46
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
9.9
97
482
R4110
NOMESCO Finland
Physiotherapy
2.2
9.6
115
624
TAB00
NOMESCO Finland
Lumbar puncture
4.9
9.5
30
65
5BA08
NOMESCO Finland
NA
22.4
9.4
13
6
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
9.4
9
*
A41.8
ICD-10 Finland
Other specified sepsis
7.6
9.4
21
29
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
9.1
88
431
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.1
8.9
16
15
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
8.6
141
869
212
Kela drug reimbursment
Gout
5.3
8.5
25
50
A98
ICPC
Health maint/preventive medicine
0.5
8.4
232
2833
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
8.4
8
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
34.2
8.1
10
*
C90.0
ICD-10 Finland
Multiple myeloma
13.4
7.9
13
10
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.6
7.8
19
30
ZX090
NOMESCO Finland
Other technic of radiotherapy
5.8
7.8
21
38
ZX108
NOMESCO Finland
Inhalation
15.5
7.8
12
8
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
46.0
7.7
9
*
Z2446
NOMESCO Finland
Social worker
3.4
7.6
36
114
RS221
NOMESCO Finland
NA
11.2
7.4
13
12
2AX05
NOMESCO Finland
NA
+∞
7.3
7
*
B37.7
ICD-10 Finland
Candidal sepsis
+∞
7.3
7
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
7.3
7
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
7.3
7
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
7.3
7
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.6
7.3
24
55
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
7.2
31
91
D64.8
ICD-10 Finland
Other specified anaemias
8.2
7.2
15
19
SPAT1088
SPAT
Blood transfusion
20.5
7.2
10
5
ED1AA
NOMESCO Finland
Mandipular X-ray examination
20.5
7.2
10
5
ZXE00
NOMESCO Finland
One hour or less
1.9
7.1
149
990
A07AA09
ATC
vancomycin; oral
8.9
6.6
13
15
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
6.6
46
189
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.4
6.5
16
26
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.1
6.4
33
113
2AA01
NOMESCO Finland
NA
+∞
6.3
6
*
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
+∞
6.3
6
*
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
6.3
6
*
G61.0
ICD-10 Finland
Guillain-Barré syndrome
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
Z2221
NOMESCO Finland
Medical doctor
1.9
6.1
104
638

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
104
32
45.76
167.87
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
112
55
29.44
154.08
7.0
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
88
23
50.73
147.55
1.3
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
88
26
44.84
142.81
2.8
2.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
93
51
24.45
120.98
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
88
46
25.20
116.69
1.5
1.6
u/ml
101.9
96.3
0.18
24
11
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
88
50
23.15
112.39
1.3
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
82
44
24.01
107.21
12.0
8.1
iu/ml
731.1
625.1
—
15
9
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
85
51
21.67
105.64
1.4
1.4
u/ml
243.6
258.1
0.08
54
30
(3048929) Epstein Barr virus Ab [Presence] in Serum
95
74
17.23
103.26
1.4
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
77
39
25.01
103.02
4.1
5.7
u/ml
711.2
875.4
—
6
5
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
71
40
22.00
90.34
1.3
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
66
40
20.09
80.92
1.3
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
44
10
50.16
74.85
4.2
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
74
66
13.94
73.28
4.5
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
74
68
13.52
71.88
4.2
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
63
49
15.45
67.47
4.5
1.7
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
58
0
+∞
62.38
1.0
0.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
121
249
6.89
60.58
8.8
3.0
e9/l
60.4
69.2
1.14
101
201
(3017181) Myelocytes/100 leukocytes in Blood
115
226
7.08
60.24
9.9
4.5
%
1.5
0.9
1.03
70
74
(44790047)
48
30
18.38
57.45
2.6
1.8
—
—
—
0
0
(44806118)
48
30
18.38
57.45
2.6
1.8
—
—
—
0
0
(44790049)
48
30
18.38
57.45
2.6
1.8
—
—
—
0
0
(44790048)
48
30
18.38
57.45
2.6
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
69
81
10.36
56.16
1.5
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
41
19
24.30
55.93
1.9
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
154
7.74
55.83
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
113
251
6.16
51.54
1.6
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
46
33
15.89
51.13
1.6
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
54
6
106.05
50.45
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
54
6
106.05
50.45
1.4
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
43
29
16.76
49.34
3.0
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
49
45
12.49
47.00
9.5
3.8
%
0.8
1.4
0.57
43
35
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
45
36
14.19
46.96
2.7
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
38
22
19.25
46.94
1.3
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
78
131
7.37
46.75
1.7
2.3
g/l
1.6
1.6
0.22
67
115
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
114
285
5.44
45.05
1.6
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
39
26
16.75
44.92
5.1
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
92
199
5.91
42.56
10.0
4.7
%
0.8
0.5
1.39
43
53
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
39
29
15.00
42.32
5.1
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
94
209
5.78
42.17
10.5
4.8
%
0.2
0.2
0.35
66
66
(3012095) Magnesium [Moles/volume] in Serum or Plasma
136
425
4.59
40.36
14.5
3.8
mmol/l
0.8
0.8
0.10
129
395
(3025159) Blasts/100 leukocytes in Blood
88
197
5.63
38.98
10.0
4.9
%
7.0
0.2
1.98
50
57
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
32
19
18.43
38.90
5.7
1.6
e6/l
359.1
508.5
—
15
8
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
27
11
26.51
38.30
2.3
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
49
10.39
38.25
2.0
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
36
12.06
37.07
9.3
4.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
84
207
5.02
32.96
4.0
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
112
350
4.23
32.38
1.7
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
28
19
15.93
31.71
6.9
1.5
e9/l
1.2
0.9
—
13
7
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
30
24
13.57
31.01
1.9
1.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
35
6
64.50
30.71
1.3
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
30
25
13.03
30.25
4.9
2.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
26
18
15.52
29.08
7.2
4.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
40
9.61
28.53
2.0
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
30
28
11.62
28.14
9.9
2.9
%
39.7
58.8
2.02
22
19
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
24
12.59
27.71
1.2
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
158
685
3.38
27.21
11.0
2.9
umol/l
315.0
6945.6
3.19
152
578
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
18
14.24
25.63
1.4
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
18
14.24
25.63
1.4
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
177
851
3.18
25.15
28.4
5.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
15
15.58
24.70
1.6
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
47
94
5.62
23.05
3.3
3.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
28
7
43.33
23.03
6.5
3.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
31
9.35
21.82
6.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
31
9.35
21.82
6.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
31
9.35
21.82
6.1
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
87
5.64
21.81
2.5
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
23
21
11.65
21.77
1.3
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
28
36
8.37
20.71
2.2
1.9
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
36
62
6.36
20.53
1.3
2.1
mg/l
40.1
13.2
0.97
31
57
(3023368) Bacteria identified in Blood by Culture
165
831
2.86
20.52
23.4
4.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
16
13.19
20.48
1.4
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
26
31
8.98
20.39
1.3
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
112
464
3.08
19.82
1.5
1.4
g/l
2.4
2.6
0.30
98
273
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
15
13.33
19.58
1.1
1.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
208
1202
2.79
19.54
26.4
6.4
%
10.5
8.8
2.29
202
1119
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
18
13
14.54
19.49
7.9
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
18
13
14.54
19.49
7.9
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
116
498
2.99
19.19
4.4
1.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
24
7
36.64
19.15
1.3
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
337
3.25
18.83
3.1
1.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
209
1227
2.74
18.76
25.4
6.2
%
33.1
26.7
7.90
203
1136
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
18
14
13.50
18.68
7.9
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
10
16.72
18.61
1.1
1.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
205
1196
2.72
18.57
24.7
6.1
%
1.8
2.8
12.83
200
1106
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
128
590
2.84
18.46
3.2
1.8
mg/l
4.4
1.3
2.27
115
452
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
29
45
6.93
18.21
2.2
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
16
11
15.19
17.72
1.1
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
18
11.10
17.47
7.7
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
18
11.10
17.47
7.7
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
18
11.10
17.47
7.7
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
18
11.10
17.47
7.7
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
87
336
3.11
17.14
3.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
21
6
37.08
16.86
1.4
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
61
194
3.60
16.39
1.3
3.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
196
1208
2.41
14.55
23.6
6.0
%
47.0
58.1
16.58
190
1126
(3044290) Cell count panel - Cerebral spinal fluid
23
38
6.41
13.57
3.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
11
12.23
12.70
2.7
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
16
5
33.41
12.68
2.0
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
148
854
2.27
12.23
18.1
2.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
8
22.24
12.12
2.2
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
20
8.33
11.97
2.8
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
20
8.33
11.97
2.8
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
21
36
6.14
11.94
7.1
2.0
pg
33.2
33.1
0.01
21
36
(40760892) CBC W Ordered Manual Differential panel - Blood
106
537
2.40
11.81
16.8
5.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
120
642
2.32
11.79
15.6
2.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
49
5.18
11.38
1.6
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
197
1311
2.15
11.03
27.2
6.3
e9/l
0.1
0.2
8.47
179
1157
(3001604) Monocytes [#/volume] in Blood
191
1264
2.12
10.76
22.5
5.9
e9/l
0.8
0.6
0.38
176
1092
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
17
8.54
10.68
3.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
17
8.54
10.68
3.0
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
191
1271
2.10
10.52
22.5
5.9
e9/l
0.0
0.0
5.23
176
1102
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
8
19.51
10.35
10.2
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
212
1481
2.09
10.09
57.1
9.5
e9/l
2.9
4.2
2.55
202
1293
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
182
1206
2.06
9.96
24.6
4.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
13
9.52
9.92
3.2
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
191
1293
2.05
9.80
22.9
6.0
e9/l
2.0
1.8
0.23
179
1151
(3042936) Bacteria identified in Isolate by Culture
83
411
2.34
9.53
2.4
1.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
13
6
22.42
9.42
3.7
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
64
286
2.51
9.19
3.3
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
21
46
4.79
9.19
2.6
1.2
mmol/l
3.8
3.9
0.26
21
41
(3003694) ABO and Rh group [Type] in Blood
114
653
2.10
9.09
2.4
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
11
9.33
8.12
2.9
1.9
u/ml
1224.6
955.5
—
10
11
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
20
6.71
8.12
3.1
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
193
1368
1.91
8.10
21.6
6.6
mmol/l
1.2
1.2
0.22
167
1136
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
129
809
1.94
7.78
6.7
3.1
u/l
30.0
33.2
0.95
124
772
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
179
1254
1.87
7.64
18.7
6.2
mmol/l
1.2
1.2
1.28
172
1115
(3023410) Appearance of Cerebral spinal fluid
11
15
7.54
7.59
3.5
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
33
5.03
7.48
5.0
1.5
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
12
9
13.75
7.43
9.0
5.9
%
39.4
52.1
—
12
9
(3024561) Albumin [Mass/volume] in Serum or Plasma
170
1184
1.85
7.28
20.1
4.5
g/l
32.4
34.8
5.38
164
1092
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
51
4.10
7.26
8.2
3.7
%
41.6
59.3
3.78
20
51
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
34
4.88
7.23
5.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
34
4.88
7.23
5.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
34
4.88
7.23
5.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
34
4.88
7.23
5.0
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
5
20.52
7.17
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
128
821
1.88
7.08
18.6
4.2
ph
7.4
7.4
1.31
22
153
(3010813) Leukocytes [#/volume] in Blood
233
2772
0.53
7.05
88.1
23.4
e9/l
10.3
6.8
0.60
227
2680
(3026361) Erythrocytes [#/volume] in Blood
233
2771
0.53
7.02
88.2
23.4
e12/l
3.7
4.4
34.75
227
2680
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
35
4.74
7.00
5.0
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
233
2770
0.53
6.98
88.2
23.4
e9/l
162.0
242.2
21.60
227
2691
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
67
3.60
6.97
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
67
3.60
6.97
1.6
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
58
3.79
6.86
4.2
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
62
313
2.19
6.66
1.9
1.7
—
—
—
0
0
(4035726)
51
239
2.33
6.53
1.7
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
22
5.61
6.33
1.7
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
197
2434
0.57
6.26
4.7
5.0
mmol/l
2.6
2.6
0.06
184
2192
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
10
16
6.40
5.99
1.4
1.0
mg/l
28.3
37.9
—
10
11
(3004789) Transferrin [Mass/volume] in Serum or Plasma
74
417
1.98
5.91
1.5
2.4
g/l
2.0
2.3
4.30
69
380
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
52
257
2.20
5.86
1.9
2.4
g/l
0.2
0.2
0.28
46
239
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
70
3.29
5.85
2.3
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
9
11.39
5.83
6.2
5.2
u/l
197.5
219.3
—
10
9
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
190
2348
0.58
5.68
50.9
15.0
ml/min/173m2
79.4
77.0
0.70
161
1934
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
7
13.15
5.61
1.4
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
7
13.15
5.61
1.8
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
62
3.36
5.54
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
70
396
1.96
5.51
1.6
2.5
%
38.7
22.1
5.52
54
342
(3001122) Ferritin [Mass/volume] in Serum or Plasma
149
1061
1.70
5.47
4.3
2.7
ug/l
860.9
137.1
3.65
140
970
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
84
2.99
5.47
3.7
3.0
u/ml
0.3
0.3
0.00
12
45
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
186
2302
0.59
5.46
5.2
6.2
mmol/mol
40.1
40.7
0.39
171
2101
(40761511) CBC panel - Blood by Automated count
220
2608
0.58
5.43
46.4
14.9
—
—
—
0
0
(3000012) Reticulocyte production index
10
18
5.69
5.35
2.3
2.2
—
—
—
0
0
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
5
0
+∞
5.22
7.6
0.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
193
2347
0.61
4.99
4.4
4.5
mmol/l
1.3
1.4
5.85
179
2112
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
165
2.32
4.85
1.6
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
227
2646
0.60
4.81
43.6
10.7
u/l
29.0
25.0
3.20
220
2528
(3032080) INR in Blood by Coagulation assay
155
1151
1.62
4.64
10.0
10.6
inr
1.2
1.3
0.36
39
332
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
23
87
2.76
4.59
1.1
4.0
—
1.4
—
0
9
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
198
2374
0.62
4.56
5.6
4.7
mmol/l
6.0
6.1
0.04
182
2124
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
21
4.87
4.56
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
44
3.52
4.52
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
30
131
2.41
4.50
7.3
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
12
7.66
4.38
3.0
2.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
9
9.06
4.30
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
9
9.06
4.30
1.4
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
13
7.07
4.18
3.0
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
83
537
1.71
4.17
4.8
4.0
ng/l
96.3
308.0
1.11
74
439
(40760888) Immunoglobulin light chains.free panel - Serum
18
63
2.96
4.12
1.2
4.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
17
58
3.03
4.07
3.2
1.4
iu/l
10.5
27.0
2.12
12
52
(40757373) Influenza virus identified in Isolate
7
7
10.17
4.02
1.0
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
14
6.56
4.01
1.1
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
191
2282
0.64
3.99
5.5
4.5
mu/l
1.9
2.0
0.09
178
2020
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
200
2364
0.64
3.95
5.0
4.5
mmol/l
4.3
4.5
1.19
188
2144
(3028433) Virus identified in Specimen by Culture
8
11
7.41
3.88
1.1
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
29
3.88
3.83
1.1
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
229
2618
0.64
3.72
57.8
18.8
mmol/l
138.7
139.6
5.34
224
2536
(3016244) Insulin [Units/volume] in Serum or Plasma
8
12
6.79
3.69
5.1
2.5
mu/l
20.4
10.1
—
8
12
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
12
6.79
3.69
1.4
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
16
5.74
3.68
3.0
1.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
36
188
2.02
3.54
9.4
6.0
mmol/l
24.8
24.4
0.28
36
177
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
6
10.14
3.51
2.7
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
103
733
1.57
3.50
2.3
2.1
mg/l
2.7
3.3
2.23
83
631
(3015377) Calcium [Moles/volume] in Serum or Plasma
120
889
1.53
3.40
6.1
3.2
mmol/l
2.3
2.3
2.49
108
760
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
10
7.12
3.38
1.3
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
7
8.69
3.27
1.2
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
117
2.22
3.25
3.2
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
11
6.47
3.20
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
93
660
1.56
3.17
44.2
6.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
48
749
0.58
3.04
4.1
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
115
862
1.50
3.03
4.2
3.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
85
602
1.54
2.90
1.9
1.8
nmol/l
1322.4
1183.2
0.59
76
445
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
83
2.36
2.89
1.2
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
7
13
5.47
2.88
1.0
1.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
9
6.76
2.88
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
9
6.76
2.88
1.3
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
196
2268
0.69
2.87
5.4
4.0
mmol/l
1.6
1.3
5.60
183
2035
(3036481) Cortisol [Moles/volume] in Serum or Plasma
41
241
1.79
2.86
2.0
2.2
nmol/l
410.4
364.8
0.89
41
222
(3047181) Lactate [Moles/volume] in Blood
18
78
2.38
2.79
7.5
6.1
mmol/l
1.3
1.3
0.11
18
69
(3019832) Treponema pallidum Ab [Presence] in Serum
28
146
2.00
2.79
1.6
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
23
3.99
2.79
5.1
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
23
3.99
2.79
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
29
510
0.53
2.79
1.3
1.2
u/ml
0.8
1.1
—
6
142
(3025941) Bacteria identified in Stool by Culture
27
140
2.01
2.73
1.5
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
10
6.08
2.71
1.0
1.1
nmol/l
112.8
130.2
—
6
10
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
113
2.11
2.68
1.4
2.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
32
3.19
2.66
1.3
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
45
279
1.70
2.62
5.0
4.6
mmol/l
1.4
1.7
0.15
35
221
(3019060) Gas panel - Arterial blood
36
209
1.81
2.62
6.4
3.8
—
—
—
0
0
(4027681)
7
15
4.74
2.61
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
68
2.42
2.59
1.1
1.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
7
7.23
2.55
1.2
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
7
7.23
2.55
1.2
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
11
5.53
2.55
1.0
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
6
11
5.53
2.55
1.0
1.5
u/l
100.5
23.8
—
6
11
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
156
1854
0.71
2.48
5.0
3.8
pmol/l
14.8
14.9
0.28
144
1639
(3037522) Nuclear Ab [Titer] in Serum
47
300
1.65
2.47
1.3
1.3
titre
669.1
420.6
0.49
11
70
(3042631) Mycobacterium sp identified in Specimen
10
35
2.91
2.32
1.8
4.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
126
1005
1.40
2.28
5.4
3.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
76
1008
0.69
2.22
4.5
5.2
ug/l
2.3
3.0
0.64
68
877
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
9
5.62
2.22
1.0
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
49
325
1.59
2.22
8.6
7.0
mmol/l
1.3
1.1
0.09
39
256
(3002173) Hemoglobin [Mass/volume] in Arterial blood
41
260
1.65
2.22
9.4
7.1
g/l
99.5
119.9
7.80
41
254
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
64
453
1.50
2.18
5.2
3.0
e6/l
3.2
2.1
0.32
37
269
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
230
2545
0.72
2.17
70.0
16.2
mg/l
36.7
26.0
3.75
218
2061
(3019225) pH of Specimen
42
270
1.63
2.16
11.7
4.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
57
794
0.66
2.14
4.3
4.7
%
20.1
21.5
0.24
28
398
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
107
840
1.39
2.10
4.2
2.4
u/l
48.1
55.6
1.74
97
777
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
17
83
2.10
2.04
1.5
3.3
g/l
0.0
0.0
0.00
17
78
(4062490)
6
15
4.05
2.04
1.7
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
44
2.55
2.03
1.2
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
137
1126
1.36
2.01
2.2
2.1
pmol/l
85.6
93.0
1.26
100
578
(3044889) 12 lead EKG panel
150
1758
0.74
1.99
6.8
4.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
21
3.38
1.97
1.1
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
17
85
2.05
1.93
1.5
3.2
g/l
0.0
0.0
0.00
17
78
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
196
0.45
1.91
2.2
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
52
2.35
1.90
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
22
3.22
1.89
1.1
1.4
—
—
—
0
0
(4094501)
0
54
0.00
1.87
0.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
198
2220
0.75
1.87
62.1
17.3
%
33.2
39.2
11.47
124
1506
(3039000) Anion gap in Blood
13
59
2.25
1.86
9.2
5.7
mmol/l
11.5
11.2
0.12
13
53
(3018572) Chloride [Moles/volume] in Blood
13
59
2.25
1.86
9.2
5.7
mmol/l
105.4
105.3
0.02
13
53
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
29
176
1.71
1.86
3.2
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
38
560
0.64
1.85
3.0
3.1
ug/l
0.9
0.9
0.06
24
382
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
138
1.79
1.84
11.4
9.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
87
2.00
1.83
1.3
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
23
3.08
1.81
12.6
3.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
88
1.98
1.78
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
88
1.98
1.78
1.3
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
36
235
1.59
1.76
10.3
9.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
36
2.54
1.75
4.7
4.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
36
2.54
1.75
1.1
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
17
90
1.93
1.68
1.5
3.1
g/l
0.0
0.0
0.00
17
83
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
175
0.44
1.62
2.4
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
61
800
0.71
1.62
3.0
3.9
mg/mmol
5.0
10.6
1.77
39
505
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
14
3.61
1.62
2.0
2.9
umol/l
25.6
26.4
—
5
14
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
14
3.61
1.62
1.6
5.5
%
110.6
95.5
—
5
14
(3009343) pH of Capillary blood
31
200
1.60
1.60
5.4
4.0
ph
7.4
7.4
—
5
17
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
20
3.03
1.58
1.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
20
3.03
1.58
1.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
20
3.03
1.58
1.0
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
25
153
1.68
1.58
5.7
3.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
135
1144
1.29
1.52
40.3
10.1
e9/l
0.0
0.0
0.66
113
935
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
21
2.89
1.51
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
21
2.89
1.51
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
21
2.89
1.51
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
21
2.89
1.51
1.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
58
2.11
1.51
5.8
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
213
0.50
1.47
1.7
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
38
2.40
1.46
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
62
474
1.37
1.41
5.2
2.9
e6/l
1.5
1.1
0.15
36
287
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
67
1.98
1.40
1.4
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
161
0.49
1.39
1.4
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
41
2.23
1.38
1.3
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
122
1415
0.79
1.31
3.6
2.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
25
2.42
1.25
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
25
2.42
1.25
1.0
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
104
872
1.27
1.24
5.4
3.3
e6/l
63.6
145.7
0.55
83
694
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
21
132
1.63
1.23
6.6
4.3
mmol/l
25.0
24.9
0.05
21
126
(3030467) Casts [#/volume] in Urine by Automated count
94
780
1.28
1.22
5.5
3.3
e6/l
0.3
0.5
0.46
73
601
(3009445) Proteinase 3 Ab [Units/volume] in Serum
17
101
1.72
1.22
1.1
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
19
2.65
1.22
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
71
1.86
1.21
1.4
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
64
798
0.76
1.21
2.4
3.0
mmol/l
7.0
7.4
0.27
59
650
(3012516) Albumin [Mass/volume] in Urine
60
752
0.76
1.17
2.4
3.1
mg/l
1150.1
229.8
0.40
42
499
(3022621) pH of Urine by Test strip
10
184
0.53
1.17
2.2
2.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
154
0.51
1.17
6.1
4.0
—
—
—
0
0
(3020891) Body temperature
18
111
1.66
1.14
6.5
4.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
30
2.36
1.13
13.0
3.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
89
743
1.27
1.10
5.6
3.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
148
0.53
1.06
3.1
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
106
0.46
1.03
2.8
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
131
1.56
1.02
1.4
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
35
2.02
1.00
1.1
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
36
1.96
0.97
2.1
3.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
31
226
1.41
0.96
3.3
3.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
11
62
1.80
0.95
2.0
2.1
g/l
109.8
129.0
1.55
11
44
(3021901) Oxygen saturation in Capillary blood
9
52
1.75
0.93
2.8
2.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
11
63
1.77
0.91
7.1
3.4
kpa
7.8
8.4
0.60
11
63
(3013290) Carbon dioxide [Partial pressure] in Blood
11
63
1.77
0.91
7.1
3.4
kpa
4.8
5.0
0.40
11
63
(3026389) Candida sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
2.0
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
189
1746
1.18
0.80
6.6
4.8
e6/l
320.1
4079.8
—
7
40
(3005033) Fetal Nuchal fold Thickness US
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
208
0.66
0.76
5.0
2.9
ml/min/173m2
62.2
62.4
—
6
91
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
28
0.00
0.76
0.0
3.0
—
23.8
—
0
19
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
17
116
1.49
0.75
3.4
4.2
%
1.7
1.5
0.45
17
108
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
118
1.46
0.70
4.0
2.8
u/ml
29.1
41.8
0.43
17
112
(3018095) Leukocytes [#/volume] in Urine
111
991
1.18
0.70
6.2
3.8
e6/l
56.7
193.2
1.04
86
739
(21494755) Public health laboratory ask at order entry panel
10
156
0.63
0.69
1.3
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
43
1.64
0.67
7.4
2.9
u/ml
25.7
33.3
—
7
43
(3023511) Choriogonadotropin [Units/volume] in Urine
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
28
218
1.31
0.62
1.7
1.5
—
—
—
0
0
(4146454)
0
21
0.00
0.60
0.0
3.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
124
0.64
0.55
3.1
2.9
u/ml
11.1
1512.4
—
8
106
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
12
82
1.48
0.55
8.4
5.5
mg/l
1.2
1.6
1.60
12
73
(3043409) Potassium [Moles/volume] in Arterial blood
14
99
1.43
0.55
6.6
3.5
mmol/l
3.5
4.0
3.06
14
88
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
91
822
1.14
0.49
3.3
2.2
u/l
136.4
284.4
1.89
85
767
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
173
1.29
0.48
1.3
1.4
—
—
—
0
0
(4034850)
5
82
0.60
0.46
9.4
11.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
85
0.58
0.46
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
36
422
0.84
0.43
20.1
27.5
inr
1.1
1.4
—
7
54
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
57
1.41
0.42
1.3
1.2
—
4.3
—
0
8
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
32
1.57
0.42
1.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
70
1.44
0.42
1.1
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
21
260
0.80
0.42
1.2
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
58
1.39
0.42
1.3
1.2
—
10.3
—
0
11
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
33
1.52
0.41
1.2
1.3
u/l
368.6
330.6
—
5
33
(3035320) C reactive protein [Mass/volume] in Body fluid
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
88
1.38
0.40
9.0
3.5
—
—
—
0
0
(4024509)
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
19
0.00
0.39
0.0
2.3
—
2.4
—
0
14
(3023199) Leukocytes [#/volume] in Pleural fluid
5
37
1.36
0.37
1.8
1.2
e6/l
3746.8
1636.9
—
5
26
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
403
0.85
0.35
1.2
1.2
iu/ml
14.0
34.5
3.24
12
142
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
46
1.31
0.33
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
57
514
1.13
0.33
2.7
3.1
mmol/l
2.4
2.5
0.36
49
440
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
284
0.83
0.33
1.9
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
117
1240
0.92
0.31
5.6
5.5
estimate
0.0
0.0
0.00
22
235
(3013512) EKG study
76
821
0.91
0.30
4.7
4.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
375
0.87
0.29
1.2
1.3
u/ml
1.0
13.4
—
7
150
(3041096) Erythrocytes [Presence] in Urine by Automated
64
695
0.90
0.28
3.2
3.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
173
1793
0.93
0.25
6.6
4.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
111
1054
1.08
0.24
2.7
2.3
nmol/l
74.5
75.7
0.17
100
920
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
39
1.29
0.23
1.2
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
120
1255
0.93
0.22
3.9
4.1
estimate
0.0
0.0
0.00
22
235
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
40
1.25
0.22
1.2
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.8
2.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.2
—
341.6
—
0
5
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
8.8
—
0
10
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
102
0.78
0.21
2.3
2.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
43
1.17
0.21
1.4
2.3
%
54.0
60.2
—
5
43
(4010399)
15
176
0.85
0.20
1.7
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.1
—
0
5
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.20
1.8
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
65
610
1.08
0.19
1.6
1.8
pmol/l
464.4
11332443.0
0.50
54
503
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
117
1126
1.06
0.17
3.7
4.0
ng/l
32.7
45.2
0.85
90
816
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
66
0.75
0.17
1.0
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
29
265
1.10
0.15
1.5
2.0
ug/g
103.4
145.8
0.70
21
204
(40768804) Tissue Pathology biopsy report
98
1018
0.95
0.15
2.7
2.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
61
578
1.07
0.14
3.9
4.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
103
1.17
0.14
1.3
3.4
g/l
0.3
0.3
—
5
37
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
94
974
0.95
0.13
3.7
4.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
126
0.87
0.11
1.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
124
1.13
0.11
2.4
2.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
47
1.06
0.09
3.0
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
121
1238
0.97
0.09
3.8
4.1
estimate
0.0
0.0
0.00
24
245
(3024928) Oxygen saturation in Venous blood
6
55
1.09
0.09
1.3
3.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
153
1556
0.97
0.08
4.9
3.2
u/l
66.6
50.9
1.10
143
1434
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
17
156
1.09
0.08
6.2
7.2
mmol/l
24.5
24.5
0.01
17
156
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
39
372
1.05
0.08
1.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
74
0.81
0.07
2.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
74
0.81
0.07
2.0
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
7
80
0.87
0.07
1.1
1.3
—
2.6
—
0
7
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
85
1.06
0.07
1.7
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
95
0.84
0.06
5.5
5.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
34
325
1.05
0.06
3.0
4.7
%
26.4
32.2
2.42
27
201
(40768797) Stomach Pathology biopsy report
32
334
0.95
0.05
1.3
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
23
218
1.06
0.05
3.6
4.0
—
—
—
0
0
(3002256) Pathology report gross observation
34
327
1.04
0.05
1.6
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
140
1.07
0.04
2.5
2.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
121
1.08
0.04
1.4
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
276
0.98
0.00
8.3
3.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
69
688
1.00
0.00
3.5
4.4
estimate
0.0
0.0
0.00
22
233
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
331
1.00
0.00
14.8
7.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
192
1916
1.00
0.00
5.0
4.1
mm/h
26.0
13.4
8.87
180
1738
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
30
305
0.98
0.00
3.6
4.0
ug/l
3.3
49.4
1.12
25
259
(3027944) Amphetamines [Presence] in Urine
7
73
0.96
0.00
2.0
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
55
550
1.00
0.00
3.7
4.5
kg/l
1.0
1.0
—
9
69
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
69
0.87
0.00
1.5
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.6
—
—
—
0
0
(4015189)
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
55
0.91
0.00
4.0
2.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
18.3
—
0
9
(3003327) Ova and parasites identified in Stool by Light microscopy
6
64
0.94
0.00
1.7
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
72
0.97
0.00
1.9
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
82
0.98
0.00
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
5.8
—
0
6
(40768800) Prostate Pathology biopsy report
5
57
0.88
0.00
1.4
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
6.2
—
7.4
—
0
6
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.0
—
5.2
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
6
65
0.92
0.00
2.8
3.5
umol/l
31.7
33.5
—
6
54
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_AML – Acute myeloid leukaemia

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).